首页> 外文期刊>Acta Chimica and Pharmaceutica Indica >Development and Validation of Colorimetric Methods for the Determination of Cinitapride Hydrogen Tartarate in Pure Drug and its Pharmaceutical Formulations
【24h】

Development and Validation of Colorimetric Methods for the Determination of Cinitapride Hydrogen Tartarate in Pure Drug and its Pharmaceutical Formulations

机译:比色法测定纯净药物中酒石酸西那必利及其药物配方的建立与验证

获取原文
           

摘要

Two simple, sensitive and highly accurate UV spectrophotometric methods (A and B) have been developed for the determination of Cinitapride Hydrogen Tartarate in pure drug and its pharmaceutical formulations. Method A is based on the diazotization of CHT with nitrous acid to form diazotized CHT, followed by its coupling with β-Naphthol to form red coloured chromogen, which shows absorption maximum at 552 nm and obeys beers law on the concentration range of 1-5 μg/mL. Method B is based on the diazotization of CHT with nitrous acid to form diazotized CHT, followed by its coupling with Chromotropic acid to form pink coloured chromogen which shows maximum absorption at 511 nm and obeys beers law in the concentration range of 4-20 μg/mL. The methods have been successfully applied for the assay of drug in pure and in pharmaceutical formulation. No interference was observed from common pharmaceutical additives. The developed methods were validated by determining its sensitivity, accuracy and precision as per ICH guidelines.
机译:已经开发了两种简单,灵敏且高度准确的紫外分光光度法(A和B),用于测定纯药物及其药物制剂中的西尼哌必利酒石酸氢盐。方法A基于CHT与亚硝酸重氮化形成重氮化CHT,然后与β-萘酚偶合形成红色色原,其在552 nm处显示最大吸收并且在1-5的浓度范围内遵守啤酒定律微克/毫升方法B基于CHT与亚硝酸重氮化以形成重氮化CHT,然后将其与变色酸偶联形成粉红色色原,在511 nm处显示最大吸收并且在4-20μg/ g的浓度范围内遵守啤酒定律毫升该方法已成功应用于纯药物制剂和药物制剂中的药物测定。没有观察到来自普通药物添加剂的干扰。通过根据ICH指南确定其灵敏度,准确性和精密度,对开发的方法进行了验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号